| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| GYRE THERAPEUTICS, INC. | Director | Stock Option (Right to Buy) | 100,000 | 07 Jan 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| GYRE | GYRE THERAPEUTICS, INC. | 07 Jan 2026 | 1 | $0 | 4 | Director | 09 Jan 2026, 16:01 |
| GYRE | GYRE THERAPEUTICS, INC. | 05 Aug 2025 | 1 | $0 | 4 | Director | 07 Aug 2025, 20:00 |
| GYRE | GYRE THERAPEUTICS, INC. | 27 May 2025 | 1 | $0 | 4 | Director | 28 May 2025, 18:13 |
| GYRE | GYRE THERAPEUTICS, INC. | 05 Jan 2025 | 1 | $0 | 4 | Director | 07 Jan 2025, 16:05 |
| GYRE | GYRE THERAPEUTICS, INC. | 05 Jan 2025 | 0 | $0 | 3 | Director | 07 Jan 2025, 16:01 |